[go: up one dir, main page]

EA200200948A1 - Лечение псориаза - Google Patents

Лечение псориаза

Info

Publication number
EA200200948A1
EA200200948A1 EA200200948A EA200200948A EA200200948A1 EA 200200948 A1 EA200200948 A1 EA 200200948A1 EA 200200948 A EA200200948 A EA 200200948A EA 200200948 A EA200200948 A EA 200200948A EA 200200948 A1 EA200200948 A1 EA 200200948A1
Authority
EA
Eurasian Patent Office
Prior art keywords
psoriasis
treatment
published
reuptake inhibitors
search report
Prior art date
Application number
EA200200948A
Other languages
English (en)
Inventor
Холли Рид Томассон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200200948A1 publication Critical patent/EA200200948A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ингибиторы обратного захвата норадреналина применяют для лечения псориаза.Отчет о международном поиске был опубликован 2002.02.07.
EA200200948A 2000-03-07 2001-02-20 Лечение псориаза EA200200948A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18750800P 2000-03-07 2000-03-07
PCT/US2001/005260 WO2001066101A2 (en) 2000-03-07 2001-02-20 Treatment of psoriasis

Publications (1)

Publication Number Publication Date
EA200200948A1 true EA200200948A1 (ru) 2003-02-27

Family

ID=22689272

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200948A EA200200948A1 (ru) 2000-03-07 2001-02-20 Лечение псориаза

Country Status (19)

Country Link
US (1) US6683114B2 (ru)
EP (1) EP1267859A2 (ru)
JP (1) JP2003525899A (ru)
KR (1) KR20020081403A (ru)
CN (1) CN1407890A (ru)
AU (1) AU4529101A (ru)
BR (1) BR0108980A (ru)
CA (1) CA2400571A1 (ru)
DZ (1) DZ3282A1 (ru)
EA (1) EA200200948A1 (ru)
HR (1) HRP20020729A2 (ru)
HU (1) HUP0204551A2 (ru)
IL (1) IL150479A0 (ru)
MX (1) MXPA02008659A (ru)
NO (1) NO20024236L (ru)
PL (1) PL357042A1 (ru)
SK (1) SK12812002A3 (ru)
WO (1) WO2001066101A2 (ru)
ZA (1) ZA200205266B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
CN2559015Y (zh) * 2002-04-29 2003-07-02 谢基生 电动式双层近红外滤光型防盗摄影监控装置
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (en) * 2003-02-28 2004-09-10 Amedis Pharmaceuticals Ltd. Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder
US20060100290A1 (en) * 2003-07-28 2006-05-11 Dunaway Leslie J Treatment of allergic rhinitis and asthma
US20100279990A1 (en) * 2006-06-13 2010-11-04 Ramot At Tel-Aviv University Ltd. Antiproliferative compounds, compositions and methods of use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
JP5973073B2 (ja) * 2013-11-08 2016-08-23 イーライ リリー アンド カンパニー アトモキセチン溶液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183323B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (ru) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Лечение неадекватного вызывающего поведения
JP2002511414A (ja) * 1998-04-09 2002-04-16 ファルマシア・アンド・アップジョン・カンパニー 神経疾患のための新しい治療
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) * 2000-03-16 2002-06-11 President And Fellows Of Harvard College Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

Also Published As

Publication number Publication date
NO20024236D0 (no) 2002-09-05
US20030045585A1 (en) 2003-03-06
CA2400571A1 (en) 2001-09-13
NO20024236L (no) 2002-09-05
MXPA02008659A (es) 2003-02-24
ZA200205266B (en) 2003-10-01
WO2001066101A2 (en) 2001-09-13
SK12812002A3 (sk) 2003-08-05
WO2001066101A3 (en) 2002-02-07
HRP20020729A2 (en) 2004-02-29
BR0108980A (pt) 2003-06-03
US6683114B2 (en) 2004-01-27
AU4529101A (en) 2001-09-17
CN1407890A (zh) 2003-04-02
DZ3282A1 (fr) 2001-09-13
EP1267859A2 (en) 2003-01-02
HUP0204551A2 (hu) 2003-06-28
KR20020081403A (ko) 2002-10-26
JP2003525899A (ja) 2003-09-02
IL150479A0 (en) 2002-12-01
PL357042A1 (en) 2004-07-12

Similar Documents

Publication Publication Date Title
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
EA200000351A1 (ru) Лечение кондуктивных нарушений
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200400971A1 (ru) Фторзамещенные циклоалканоиндолы, композиции, содержащие такие соединения, и способы лечения
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
EA200000349A1 (ru) Способ лечения оппозиционного расстройства
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
ATE423557T1 (de) Carbocyclische kaliumkanalhemmer
DE69924135D1 (de) Heterozyklische kalium-kanal inhibitoren
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
ATE461697T1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
EA200401183A1 (ru) Применение ингибиторов il-18 в качестве диагностического маркера
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
EA200200948A1 (ru) Лечение псориаза
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
SE9801494D0 (sv) Novel use
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
EP1667976A4 (en) Isoquinolinone POTASSIUM CHANNEL INHIBITORS
EP1274414A4 (en) NASAL ADMINISTRATION OF AGENTS TO TREAT GASTROPARESIA
EA199800152A1 (ru) Лечение синдрома дефицита внимания/гиперактивности